Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,652 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ordered Photoexfoliation for Polypseudorotaxane Nanosheets.
Liu M, Wu B, Shen S, Sun H, Gu X, Li S, Tang Z, Cheng J, Ma X, Zhang M, Xu Y, Zhu L. Liu M, et al. Among authors: tang z. ACS Macro Lett. 2025 Jan 21;14(1):93-100. doi: 10.1021/acsmacrolett.4c00815. Epub 2025 Jan 5. ACS Macro Lett. 2025. PMID: 39757546
Advances in RNA therapy for the treatment of autoimmune diseases.
Zhang Y, Zang C, Mao M, Zhang M, Tang Z, Chen W, Zhu W. Zhang Y, et al. Among authors: tang z. Autoimmun Rev. 2025 Jan 20:103753. doi: 10.1016/j.autrev.2025.103753. Online ahead of print. Autoimmun Rev. 2025. PMID: 39842534 Review.
Protective effect of ulinastatin against negative inflammatory response and organ dysfunction in acute aortic dissection surgery: The PANDA trial.
Liu H, Qian SC, Zhu K, Diao YF, Xu XF, Tang ZW, Fan GL, Yue HH, Chen JQ, Yang JN, Zhang YY, Ma C, Liu X, Wu Y, Wu Z, Liu N, Li A, Ni BQ, Shao YF, Zhao S, Li HY, Zhang HJ; China Additive Anti-inflammatory Actions for Aortopathy and Arteriopathy (5A); PANDA Trial Investigators. Liu H, et al. Among authors: tang zw. Cell Rep Med. 2025 Jan 21;6(1):101888. doi: 10.1016/j.xcrm.2024.101888. Cell Rep Med. 2025. PMID: 39842406 Clinical Trial.
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells.
Zhu GQ, Tang Z, Chu TH, Wang B, Chen SP, Tao CY, Cai JL, Yang R, Qu WF, Wang Y, Zhao QF, Huang R, Tian MX, Fang Y, Gao J, Wu XL, Zhou J, Liu WR, Dai Z, Shi YH, Fan J. Zhu GQ, et al. Among authors: tang z. Signal Transduct Target Ther. 2025 Jan 22;10(1):25. doi: 10.1038/s41392-024-02118-2. Signal Transduct Target Ther. 2025. PMID: 39837814 Free article.
12,652 results
You have reached the last available page of results. Please see the User Guide for more information.